Hepatitis B virus prevalence in rural areas in south-west Chad

Abstract

In Chad, hepatitis B virus (HBV) is thought to have a high prevalence and is consequently responsible for numerous acute and long-term complications. It is often detected during screening in potential blood donors. However, no general population-based study on the prevalence of hepatitis B has been performed. The aim of this study was to gain an impression of the HBV prevalence in rural areas in south-west Chad. A total of 1309 individuals (745 boys/men, 564 girls/women) with a median age of 15 years (age range, 6–81 years) were screened for the presence of the hepatitis B antigen (HBsAG). We found an overall prevalence of 22.9%. The youngest age group (6–15 years) and the boys/men showed a significantly higher HBsAG prevalence compared to the older groups and the girls/women, respectively (P < 0.01). Vertical infection during birth and horizontal infection by sharing food, water and shelter are believed to be the main sources of infection.

Keywords

Hepatitis B prevalence Chad sub-Saharan Africa

Get full access to this article

View all access options for this article.

References

World Health Organization. Hepatitis B. Geneva: WHO, 2002.

EASL. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167–185.

Hyams

. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20: 992–1000.

McMahon

Alward

Hall

et al.

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599–603.

World Health Organization. Treatment of Persons with Chronic Hepatitis B Infection. Geneva: WHO, 2015. Available at: https://www.ncbi.nlm.nih.gov/books/NBK305548.

Lozano

Naghavi

Foreman

et al.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013; 380: 2095–2128.

Mast

Alter

Margolis

. Strategies to prevent and control hepatitis B and C virus infections: A global perspective. Vaccine 1999; 17: 1730–1733.

Beasley

Hwang

Lee

et al.

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 322: 1099–1102.

Kramvis

Kew

. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007; 37(Suppl. 1): 9–19.

10.

Hwang

Cheung

. Global epidemiology of hepatitis B virus (HBV) infection. North Am J Med Sci 2011; 14: 7–13.

11.

Ott

Stevens

Groeger

et al.

Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30: 2212–2219.

12.

Kiire

. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut 1996; 38(Suppl. 2): S5–12.

13.

Franzeck

Ngwale

Msongole

et al.

Viral hepatitis and rapid diagnostic test based screening for HBsAg in HIV-infected patients in rural Tanzania. PLoS One 2013; 8: e58468–e58468.

14.

Tao

Compaoré

Diarra

et al.

Seroepidemiology of hepatitis B and C viruses in the general population of Burkina Faso. Hepat Res Treat 2014; 2014: 781843–781843.

15.

Onyekwere

Hameed

. Hepatitis B and C virus prevalence and association with demographics: report of population screening in Nigeria. Trop Doct 2014; 45: 231–235.